spacer
home > pmps > summer 2019 > certified solutions for tempertaure control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Certified Solutions for Tempertaure Control

Every day, Swiss WorldCargo ships pharmaceutical goods throughout the world, requiring innovative solutions and fast-paced handling. Of the items shipped across the globe, many are life-saving medicines or life sciences solutions, so it’s no surprise that Swiss WorldCargo’s product portfolio is set up in order to best suit the diverse, complex needs of its clients.

For its temperature-sensitive pharmaceutical shipments, Swiss WorldCargo offers three main products:

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Swiss WorldCargo is the airfreight division of Swiss International Air Lines (SWISS). Headquartered at Zurich Airport, Swiss WorldCargo offers a comprehensive range of logistics solutions for transporting high-value and care-intensive consignments to some 130 destinations in over 84 countries. The extensive Swiss WorldCargo network of airfreight services is further supplemented by daily truck connections between key business centres. As a reliable and innovative service provider within the Lufthansa Group, Swiss WorldCargo is consistently committed to delivering Swiss quality to its airfreight customers and makes a substantial contribution to SWISS’s overall profitability.
spacer
Swiss WorldCargo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman

Daresbury, UK, 24 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve takes over the position from Paul Foulger, who was serving as Chairman on an interim basis on behalf of the Board.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement